Prof. Dr. med. Beata BODE-LESNIEWSKA Institute of Pathology and Molecular Pathology University Hospital; Zurich

Size: px
Start display at page:

Download "Prof. Dr. med. Beata BODE-LESNIEWSKA Institute of Pathology and Molecular Pathology University Hospital; Zurich"

Transcription

1 Prof. Dr. med. Beata BODE-LESNIEWSKA Institute of Pathology and Molecular Pathology University Hospital; Zurich 32 year old man 2 months history of growing left supraclavicular lymph nodes Antibiotic treatment was not successful Thoraco-abdominal staging (at first CT, than PET-CT)

2 PET-CT performed prior to the FNAC of the leftsupraclavicular mass Aug 18th

3 32 year old man 2 months history of growing left supraclavicular lymph nodes Antibiotic treatment was not successful Thoraco-abdominal staging (at first CT, than PET- CT) showed large retroperitoneal, mediastinal and left supraclavicular tumor masses based on imaging the strong clinical suspicion of a lymphoma has been rendered. Sonographically guided FNAC of the left supraclavicular lymph node

4 Sonographically guided FNAC of the pathologic lymph nodes (pln) pln pln Aug 18th

5 Direct smear PAP stain; 100x

6 Direct smear PAP stain; 50x

7 Direct smear PAP stain; 200x

8 Direct smear PAP stain; 200x

9 Direct smear PAP stain; 200x

10 Direct smear PAP stain; 400x

11 Direct smear PAP stain; 400x

12 Cell block HE stain; 100x

13 Cell block Mib1; 200x

14 Differential diagnosis Carcinoma Melanoma Lymphoma Hodgkin Non-Hodgkin (anaplastic) Sarcoma (e.g. epithelioid sarcoma, angiosarcoma, etc ) Germ cell tumor (Mesothelioma)

15 Cell block Cytokeratin (AE1/AE3); 200x

16 FNAC lymph node Cell block; 200x CD20 CD3

17 FNAC lymph node Cell block; 400x CD45 CD30 Alk1 S100, ERG, CD34, CD31 INI1 expression present

18 Differential diagnosis Carcinoma Melanoma Lymphoma Hodgkin Non-Hodgkin Sarcoma Germ cell tumor Mesothelioma

19 Cell block OCT3/4; 400x

20 Cell block PLAP; 400x

21 FNAC lymph node Cell block; 200x SALL4 bhcg

22 Direct smear PAP stain; 400x Germ cell tumor (seminoma) (19.8.)

23 Aug 19th

24 Urology consult

25 Semicastration

26

27 PLAP Germ cell neoplasia in situ (GCNIS)

28 Final diagnosis Metastatic (at presentation) seminoma Extensive metastases retroperitoneal and left cervical Initial manifestation as supraclavicular lymphadenopathy «Burnt out» (regressed) germ cell tumor of the right testis Semicastration with focal scaring Advanced atrophy of the tubuli Germ cell neoplasia in situ (GCNIS) present

29 Post 4 months chemotherapy Initial PET-C (at presentation)

30 Follow up Recurrent tumor 6 month after initial presentation High dose chemotherapy with autologous bone marrow transplantation successful Local lumbal spine radiotherapy for residual tumor 6 years after initial presentation no further tumor manifestations declared as cured

31 Germ cell Tumors (GCT) Rare (1% of male malignancy) Incidence / (higher in industrialiezed countries) Ethnicity / genetic susceptibility Enviromental factors however - most common cancer among young male patients (puberty to 40-ies) in industrialized countries High metastatic potential Accompanied by tumor markers in blood (AFP, bhcg) Curable with modern combined therapy regimens (most important chemotherapy)

32 Usual presentation as a testicular mass Some 3-10% of seminomas and embryonal carcinomas present as a metastatic disease Practically all choriocarcinomas are metastatic at presentation «Burnt out» (regressed) testicular tumors May cause bulky metastatic diesease Should not be confused with (rare) extragonadal primaries (retroperitoneum, mediastinum)

33 GCT - Subtypes Seminoma Non-seminomatous GCT Embryonal carcinoma Yolk sac tumor Choriocarcinoma Teratomas Mixed GCT

34 Cytologic diagnosis of GCT Not on primary tumors Possible in metastatic setting First diagnosis, if testicular primary not obvious Recurrent tumor Advantage: rapid turn over time final pathologic tissue diagnosis within 2 days No excisional biopsy neccessary Semicastration on the 4th day Disease specific diagnosis chemotherapy prompty started

35 Facit Metastatic germ cell tumor (GCT) may cause cervial lymphydenopathy (not only retroperitoneal / mediastinal) Cytologic diagnosis of GCT is well feasible GCT should be considered as a differential diagnosis especially in young male patients with rapidly progressive lymphadenopathy

36

Disclosure of Relevant Financial Relationships

Disclosure of Relevant Financial Relationships Evening Specialty Conference - Genitourinary Pathology Case 2 Disclosure of Relevant Financial Relationships Sean R Williamson, MD Henry Ford Health System, Detroit, MI @Williamson_SR USCAP requires that

More information

Uncommon secondary tumour of the stomach

Uncommon secondary tumour of the stomach Uncommon secondary tumour of the stomach B. Bancel, Hôpital CROIX ROUSSE LYON Bucharest Nov 2013 Case report 33-year old man Profound mental retardation and motor disturbances (sequelae of neonatal meningeal

More information

STAGING AND FOLLOW-UP STRATEGIES

STAGING AND FOLLOW-UP STRATEGIES ATHENS 4-6 October 2018 European Society of Urogenital Radiology STAGING AND FOLLOW-UP STRATEGIES Ahmet Tuncay Turgut, MD Professor of Radiology Hacettepe University, Faculty of Medicine Ankara 2nd ESUR

More information

Cardiff MRCS OSCE Courses Testicular Cancer

Cardiff MRCS OSCE Courses  Testicular Cancer Testicular Cancer Scenario: A 40-year-old male presents to the surgical out-patient clinic with a 6-8 week history of a painless lump in his left scrotum. He however complains of a dull ache in the scrotum

More information

ANZUP SURVEILLANCE RECOMMENDATIONS FOR METASTATIC TESTICULAR CANCER POST-CHEMOTHERAPY

ANZUP SURVEILLANCE RECOMMENDATIONS FOR METASTATIC TESTICULAR CANCER POST-CHEMOTHERAPY ANZUP SURVEILLANCE RECOMMENDATIONS FOR METASTATIC TESTICULAR CANCER POST-CHEMOTHERAPY Note: These surveillance recommendations are provided as recommendations only. Clinicians should take into account

More information

Male Genital Cancers in the US in Frequency of Types

Male Genital Cancers in the US in Frequency of Types Germ Cell Tumors of the Testis Pathology, Immunohistochemistry, and the Often Confusing Appearance of Their Metastases Charles Zaloudek, MD Department of Pathology UCSF Male Genital Cancers in the US in

More information

GUIDELINES ON TESTICULAR CANCER

GUIDELINES ON TESTICULAR CANCER 38 (Text updated March 2005) P. Albers (chairman), W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, A. Horwich, O. Klepp, M.P. Laguna, G. Pizzocaro Introduction Compared with other types of cancer

More information

Testicular Germ Cell Tumors; A Simplistic Approach

Testicular Germ Cell Tumors; A Simplistic Approach Testicular Germ Cell Tumors; A Simplistic Approach Merce Jorda, MD, PhD, MBA Professor and Vice Chair, Director of Anatomic Pathology Director of Genitourinary Pathology Service Interim Director of Cytopathology

More information

International Journal of Case Reports in Medicine

International Journal of Case Reports in Medicine International Journal of Case Reports in Medicine Vol. 2013 (2013), Article ID 616832, 20 minipages. DOI:10.5171/2013.616832 www.ibimapublishing.com Copyright 2013 A. L. Hemalatha, Nishtha Batra, Deepthi.

More information

Doppler ultrasound of the abdomen and pelvis, and color Doppler

Doppler ultrasound of the abdomen and pelvis, and color Doppler - - - - - - - - - - - - - Testicular tumors are rare in children. They account for only 1% of all pediatric solid tumors and 3% of all testicular tumors [1,2]. The annual incidence of testicular tumors

More information

-The cause of testicular neoplasms remains unknown

-The cause of testicular neoplasms remains unknown - In the 15- to 34-year-old age group, they are the most common tumors of men. - include: I. Germ cell tumors : (95%); all are malignant. II. Sex cord-stromal tumors: from Sertoli or Leydig cells; usually

More information

Germ cell tumours UK SH. Ivo Leuschner. Kiel Pediatric Tumor Registry, Institute of Pathology University Hospital of Schleswig-Holstein Campus Kiel

Germ cell tumours UK SH. Ivo Leuschner. Kiel Pediatric Tumor Registry, Institute of Pathology University Hospital of Schleswig-Holstein Campus Kiel Germ cell tumours Ivo Leuschner Kiel Pediatric Tumor Registry, Institute of Pathology University Hospital of Schleswig-Holstein Campus Kiel UK SH Old histogenetic Concept of Germ cell tumours Pluripotent

More information

Clinical summary. Male 30 year-old with past history of non-seminomous germ cell tumour. Presents with retroperitoneal lymphadenopathy on CT.

Clinical summary. Male 30 year-old with past history of non-seminomous germ cell tumour. Presents with retroperitoneal lymphadenopathy on CT. Clinical summary Male 30 year-old with past history of non-seminomous germ cell tumour. Presents with retroperitoneal lymphadenopathy on CT. For restaging PET/CT. PET/CT findings No significant FDG uptake

More information

Regressed Testicular Seminoma with Extensive Metastases. S Andhavarapu, B Low, J Raj, S Skinner, J Armenta-Corona

Regressed Testicular Seminoma with Extensive Metastases. S Andhavarapu, B Low, J Raj, S Skinner, J Armenta-Corona ISPUB.COM The Internet Journal of Oncology Volume 5 Number 1 S Andhavarapu, B Low, J Raj, S Skinner, J Armenta-Corona Citation S Andhavarapu, B Low, J Raj, S Skinner, J Armenta-Corona.. The Internet Journal

More information

Fellow GU Lecture Series, Testicular Cancer. Asit Paul, MD, PhD 02/06/2018

Fellow GU Lecture Series, Testicular Cancer. Asit Paul, MD, PhD 02/06/2018 Fellow GU Lecture Series, 2018 Testicular Cancer Asit Paul, MD, PhD 02/06/2018 Rare cancer worldwide, approximately 1% of all male cancers There is a large difference among ethnic/racial groups. Rates

More information

Genetic Studies of Dysgerminoma

Genetic Studies of Dysgerminoma Genetic Studies of Chromosome 12p abnormalities are characteristic of germ cell tumors isochromosome 12p and 12p overrepresentation Some can be detected by karyotyping FISH study of 21 dysgerminomas showed

More information

Testicular Malignancies /8/15

Testicular Malignancies /8/15 Collecting Cancer Data: Testis 2014-2015 NAACCR Webinar Series January 8, 2015 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

Fellow GU Lecture Series, Testicular Cancer. Asit Paul, MD, PhD 02/06/2018

Fellow GU Lecture Series, Testicular Cancer. Asit Paul, MD, PhD 02/06/2018 Fellow GU Lecture Series, 2018 Testicular Cancer Asit Paul, MD, PhD 02/06/2018 Rare cancer worldwide, approximately 1% of all male cancers There is a large difference among ethnic/racial groups. Rates

More information

Note: The cause of testicular neoplasms remains unknown

Note: The cause of testicular neoplasms remains unknown - In the 15- to 34-year-old age group, they are the most common tumors of men. - Tumors of the testis are a heterogeneous group of neoplasms that include: I. Germ cell tumors : 95%; all are malignant.

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Hematopoietic Stem-Cell Transplantation in the Treatment of Germ File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_in_the_treatment_of_germ_cell_tumor

More information

Mediastinal Germ Cell Tumors

Mediastinal Germ Cell Tumors Mediastinal Germ Cell Tumors Anja C. Roden, M.D. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA 2018 MFMER slide-1 Disclosure I have no relevant financial relationships

More information

Case Report Seminoma Presenting as Renal Mass, Inferior Vena Caval Thrombus, and Regressed Testicular Mass

Case Report Seminoma Presenting as Renal Mass, Inferior Vena Caval Thrombus, and Regressed Testicular Mass Case Reports in Urology Volume 2015, Article ID 835962, 4 pages http://dx.doi.org/10.1155/2015/835962 Case Report Seminoma Presenting as Renal Mass, Inferior Vena Caval Thrombus, and Regressed Testicular

More information

"Burned out" testicular tumor: Clinical and radiological features

Burned out testicular tumor: Clinical and radiological features "Burned out" testicular tumor: Clinical and radiological features Poster No.: C-0799 Congress: ECR 2012 Type: Educational Exhibit Authors: G. Viteri, I. Simon Yarza, R. Saiz-Mendiguren, J. Arias, A. Villanueva

More information

ISPUB.COM. Mediastinal Seminoma: A Case Report. F Gândara, A Leitão, M Bernardo, S Ramos, I João, F Ceia INTRODUCTION CASE REPORT

ISPUB.COM. Mediastinal Seminoma: A Case Report. F Gândara, A Leitão, M Bernardo, S Ramos, I João, F Ceia INTRODUCTION CASE REPORT ISPUB.COM The Internet Journal of Internal Medicine Volume 9 Number 1 F Gândara, A Leitão, M Bernardo, S Ramos, I João, F Ceia Citation F Gândara, A Leitão, M Bernardo, S Ramos, I João, F Ceia.. The Internet

More information

EAU GUIDELINES ON TESTICULAR CANCER

EAU GUIDELINES ON TESTICULAR CANCER EAU GUIDELINES ON TESTICULAR CANCER (Limited text update March 2018) P. Albers (Chair), W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi, A. Horwich, M.P. Laguna (Vice-chair), N. Nicolai,

More information

Testicular Tumors: What s New, True, Important Cristina Magi-Galluzzi, MD, PhD

Testicular Tumors: What s New, True, Important Cristina Magi-Galluzzi, MD, PhD Testicular Tumors: What s New, True, Important Cristina Magi-Galluzzi, MD, PhD Director, Genitourinary Pathology R.J. Tomsich Pathology & Laboratory Medicine Institute Professor of Pathology, Lerner College

More information

Running Title: Utility of HCG Washout in Cervical LND FNA

Running Title: Utility of HCG Washout in Cervical LND FNA AACE Clinical Case Reports Rapid Electronic Articles in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited,

More information

New Developments in Immunohistochemistry for Gynecologic Pathology

New Developments in Immunohistochemistry for Gynecologic Pathology New Developments in Immunohistochemistry for Gynecologic Pathology Michael T. Deavers, M.D. Professor, Departments of Pathology and Gynecologic Oncology Immunohistochemistry in Gynecologic Pathology Majority

More information

Ultrasound of malignant testicular lesions. Arne Hørlyck Department of Radiology Aarhus University Hospital, Skejby

Ultrasound of malignant testicular lesions. Arne Hørlyck Department of Radiology Aarhus University Hospital, Skejby Ultrasound of malignant testicular lesions Arne Hørlyck Department of Radiology Aarhus University Hospital, Skejby Testis Ultrasound is fantastic!! Scrotum Extratesticular mass: Benign Intratesticular

More information

Leukaemia 35% Lymphoma 14%

Leukaemia 35% Lymphoma 14% Distribution ib ti of Cancers in Children under 15 years Leukaemia 35% Lymphoma 14% Neuroblastoma 9% Other 5% Liver 1% Retinoblastoma 3% Bone and STS 15% CNS 20% Wilms' 8% 30-40% Mortality Germ Cell Tumours

More information

HODGKIN LYMPHOMA DR. ALEJANDRA ZARATE OSORNO HOSPITAL ESPAÑOL DE MEXICO

HODGKIN LYMPHOMA DR. ALEJANDRA ZARATE OSORNO HOSPITAL ESPAÑOL DE MEXICO HODGKIN LYMPHOMA DR. ALEJANDRA ZARATE OSORNO HOSPITAL ESPAÑOL DE MEXICO HODGKIN LYMPHOMA CLASSIFICATION Lukes & Butler Rye WHO-2016 Linphocytic and/or histiocytic Nodular & diffuse Nodular Sclerosis Lymphocyte

More information

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site POLICY: PG0364 ORIGINAL EFFECTIVE: 04/22/16 LAST REVIEW: 07/26/18 MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site GUIDELINES This policy does not certify benefits or authorization

More information

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC Cancers of unknown primary : Knowing the unknown Prof. Ahmed Hossain Professor of Medicine SSMC Definition Cancers of unknown primary site (CUPs) Represent a heterogeneous group of metastatic tumours,

More information

EAU GUIDELINES ON TESTICULAR CANCER

EAU GUIDELINES ON TESTICULAR CANCER EAU GUIDELINES ON TESTICULAR CANCER (Limited text update March 2015) P. Albers (Chair), W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi, A. Horwich, M.P. Laguna, N. Nicolai, J. Oldenburg

More information

Management of Neck Metastasis from Unknown Primary

Management of Neck Metastasis from Unknown Primary Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough

More information

EAU GUIDELINES ON TESTICULAR CANCER

EAU GUIDELINES ON TESTICULAR CANCER EU GUIDELINES ON TESTICULR CNCER (Limited text update March 2017) P. lbers (Chair), W. lbrecht, F. lgaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi,. Horwich, M.P. Laguna, N. Nicolai, J. Oldenburg Introduction

More information

Testicular Cancer. J. Richard Auman, MD. James J. Stark, MD. Jerry Singer, MD. September 19, 2008

Testicular Cancer. J. Richard Auman, MD. James J. Stark, MD. Jerry Singer, MD. September 19, 2008 Testicular Cancer J. Richard Auman, MD James J. Stark, MD Jerry Singer, MD September 19, 2008 Testicular Cancer From mystery to far-advanced disease: a remarkable case Case Presentation. 23 y. o. male

More information

Quiz 1. Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios.

Quiz 1. Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios. Quiz 1 Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios. 1. 62 year old Brazilian female Race 1 Race 2 Spanish/Hispanic Origin 2. 43 year old Asian male born in Japan Race 1

More information

ESMO Consensus Empfehlungen 2017

ESMO Consensus Empfehlungen 2017 ESMO Consensus Empfehlungen 2017 What s old, what s new, what s missing? Jörg Beyer, Klinik für Onkologie Offenlegung Interessenskonflikte 1. Anstellungsverhältnis oder Führungsposition Keine 2. Beratungs-

More information

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules Case 1 72 year old white female presents with a nodular thyroid. This was biopsied in

More information

Lugano classification: Role of PET-CT in lymphoma follow-up

Lugano classification: Role of PET-CT in lymphoma follow-up CAR Educational Exhibit: ID 084 Lugano classification: Role of PET-CT in lymphoma follow-up Charles Nhan 4 Kevin Lian MD Charlotte J. Yong-Hing MD FRCPC Pete Tonseth 3 MD FRCPC Department of Diagnostic

More information

NICaN Testicular Germ Cell Tumours SACT protocols

NICaN Testicular Germ Cell Tumours SACT protocols Reference No: Title: Author(s) Ownership: Approval by: Systemic Anti-Cancer Therapy (SACT) Guidelines for Germ Cell Tumours Dr Audrey Fenton Consultant Medical Oncologist, Dr Vicky Coyle Consultant Medical

More information

Testicular cancer and other germ cell tumours. London Cancer Jonathan Shamash

Testicular cancer and other germ cell tumours. London Cancer Jonathan Shamash Testicular cancer and other germ cell tumours London Cancer 2018 Jonathan Shamash Background Testicular germ cell tumours are the commonest cancers of young men Overall they are curable but long term side

More information

Adenocarcinoma of the Cervix

Adenocarcinoma of the Cervix Question 1. Each of the following statements about cervical adenocarcinoma is true except: Adenocarcinoma of the Cervix SAMS a) A majority of women with cervical adenocarcinoma have stage I tumors at diagnosis.

More information

Tumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors.

Tumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors. Tumour Markers What are Tumour Markers? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer

More information

Populations Interventions Comparators Outcomes Individuals: With previously untreated germ cell tumors

Populations Interventions Comparators Outcomes Individuals: With previously untreated germ cell tumors Hematopoietic Cell Transplantation in the Treatment of Germ Cell (80135) (Formerly Hematopoietic Stem Cell Transplantation in the Treatment of Germ Cell ) Medical Benefit Effective Date: 04/01/13 Next

More information

Cancer of Unknown Primary (CUP)

Cancer of Unknown Primary (CUP) Cancer of Unknown Primary (CUP) Pathways and Guidelines V1.0 London Cancer September 2013 The following pathways and guidelines document has been compiled by the London Cancer CUP technical subgroup and

More information

Cancer of Unknown Primary (CUP) Protocol

Cancer of Unknown Primary (CUP) Protocol 1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date

More information

Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R

Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R 2 0 1 2 Objectives Discuss Diagnostic and staging strategies in oncology Know

More information

GERM-CELL TUMOURS. ESMO Preceptorship on Adolescents and Young Adults with cancer Lugano, May 2018

GERM-CELL TUMOURS. ESMO Preceptorship on Adolescents and Young Adults with cancer Lugano, May 2018 ESMO Preceptorship on Adolescents and Young Adults with cancer Lugano, 11-12 May 2018 GERM-CELL TUMOURS Giannis Mountzios MSc, PhD Medical Oncology University of Athens School of Medicine Athens, Greece

More information

Protocol for the Examination of Lymphadenectomy Specimens From Patients With Malignant Germ Cell and Sex Cord-Stromal Tumors of the Testis

Protocol for the Examination of Lymphadenectomy Specimens From Patients With Malignant Germ Cell and Sex Cord-Stromal Tumors of the Testis Protocol for the Examination of Specimens From Patients With Malignant Germ Cell and Sex Cord-Stromal Tumors of the Testis Version: Testis 4.0.1.1 Protocol Posting Date: February 2019 Accreditation Requirements

More information

Pathology of Mediastinal Tumors

Pathology of Mediastinal Tumors SAMO Meeting Lucerne 2009 Pathology of Mediastinal Tumors Alex Soltermann Most common lesions (adults) Clinical presentation 50% of the patients are asymptomatic, lesion discovered incidentally Symptoms

More information

Ovarian Tumors. Andrea Hayes-Jordan MD FACS, FAAP Section Chief, Pediatric Surgery/Surgical Onc. UT MD Anderson Cancer Center

Ovarian Tumors. Andrea Hayes-Jordan MD FACS, FAAP Section Chief, Pediatric Surgery/Surgical Onc. UT MD Anderson Cancer Center Ovarian Tumors Andrea Hayes-Jordan MD FACS, FAAP Section Chief, Pediatric Surgery/Surgical Onc. UT MD Anderson Cancer Center Case 13yo female with abdominal pain Ultrasound shows huge ovarian mass Surgeon

More information

IJPHCS Open Access: e-journal

IJPHCS Open Access: e-journal PRIMARY MEDIASTINAL CHORIOCARCINOMA MASQUERADING AS LUNG METASTASIS: A RARE DISEASE WITH A FATAL OUTCOME Balakrishnan D 1, Suppiah S 2, 3, Md. Sidek S 1, Noriah O 4 1 Department of Diagnostik Imaging,

More information

Citation for published version (APA): Lutke Holzik, M. F. (2007). Genetic predisposition to testicular cancer s.n.

Citation for published version (APA): Lutke Holzik, M. F. (2007). Genetic predisposition to testicular cancer s.n. University of Groningen Genetic predisposition to testicular cancer Lutke Holzik, Martijn Frederik IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite

More information

Exercise. Discharge Summary

Exercise. Discharge Summary Exercise Discharge Summary A 32-year-old Brazilian male presented with a 6 month history of right-sided scrotal swelling. Backache was present for 2 months and a history of right epididymitis was present

More information

Neoplasia 2018 lecture 11. Dr H Awad FRCPath

Neoplasia 2018 lecture 11. Dr H Awad FRCPath Neoplasia 2018 lecture 11 Dr H Awad FRCPath Clinical aspects of neoplasia Tumors affect patients by: 1. their location 2. hormonal secretions 3. paraneoplastic syndromes 4. cachexia Tumor location Even

More information

Hepatic Resection of Metastatic Testicular Carcinoma: A Further Update

Hepatic Resection of Metastatic Testicular Carcinoma: A Further Update Annals of Surgical Oncology, 6(7):640 644 Published by Lippincott Williams & Wilkins 1999 The Society of Surgical Oncology, Inc. Hepatic Resection of Metastatic Testicular Carcinoma: A Further Update Tara

More information

Karoline Nowillo, MD. February 1, 2008

Karoline Nowillo, MD. February 1, 2008 Case Presentation Karoline Nowillo, MD SUNY Downstate t February 1, 2008 Case Presentation Chief complaint enlarging goiter x 8 months History of present illness shortness of breath, heaviness in chest

More information

Five patients needing radiation but no in-country access. Memory Nsingo 15 December 2015

Five patients needing radiation but no in-country access. Memory Nsingo 15 December 2015 Five patients needing radiation but no in-country access Memory Nsingo 15 December 2015 Radiotherapy project update Remigio Makufa GPH Oncology Physicist MGH ATTACHMENT THERAPIST -January 2015 Clinical

More information

ASYMPTOMATIC COMPLEX TESTICULAR NEOPLASIA ASSOCIATED WITH ORCHIEPIDIDYMITIS. CASE REPORT

ASYMPTOMATIC COMPLEX TESTICULAR NEOPLASIA ASSOCIATED WITH ORCHIEPIDIDYMITIS. CASE REPORT Rev. Med. Chir. Soc. Med. Nat., Iaşi 2017 vol. 121, no. 4 SURGERY CASE REPORTS ASYMPTOMATIC COMPLEX TESTICULAR NEOPLASIA ASSOCIATED WITH ORCHIEPIDIDYMITIS. CASE REPORT Ș. Iacob 1, R. Vrînceanu 2,3, B.

More information

Chemotherapy for Urological Cancers

Chemotherapy for Urological Cancers Chemotherapy for Urologic Cancers Matthew Rettig, MD Associate Professor Department of Medicine Division of Hematology-Oncology Department of Urology Medical Director, Prostate Cancer Program Institute

More information

Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy

Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy Stephanie Yap, M.D. University Gynecologic Oncology Northside Cancer Institute Our Learning Objectives Review survival rates,

More information

The Importance of One-Stage Median Stemotomy and Retroperitoneal Node Dissection in Disseminated Testicular Cancer

The Importance of One-Stage Median Stemotomy and Retroperitoneal Node Dissection in Disseminated Testicular Cancer The Importance of One-Stage Median Stemotomy and Retroperitoneal Node Dissection in Disseminated Testicular Cancer Isidore Mandelbaum, M.D., Peter B. Yaw, M.D., Lawrence H. Einhorn, M.D., Stephen D. Williams,

More information

Teratocarcinoma In A Young Boy- An Unusual Presentation

Teratocarcinoma In A Young Boy- An Unusual Presentation Human Journals Case Report November 2015 Vol.:2, Issue:1 All rights are reserved by Atia Zaka-ur-Rab et al. Teratocarcinoma In A Young Boy- An Unusual Presentation Keywords: Boy, Testicular Mass, Teratocarcinoma

More information

Clinical indications for positron emission tomography

Clinical indications for positron emission tomography Clinical indications for positron emission tomography Oncology applications Brain and spinal cord Parotid Suspected tumour recurrence when anatomical imaging is difficult or equivocal and management will

More information

CASE REPORT A CASE OF MEDIASTINAL EMBRYONAL CARCINOMA SUCCESSFULLY TREATED BY INTEGRATIVE THERAPY

CASE REPORT A CASE OF MEDIASTINAL EMBRYONAL CARCINOMA SUCCESSFULLY TREATED BY INTEGRATIVE THERAPY Nagoya J. Med. Sci. 76. 225 ~ 233, 2014 CASE REPORT A CASE OF MEDIASTINAL EMBRYONAL CARCINOMA SUCCESSFULLY TREATED BY INTEGRATIVE THERAPY KATSUHISA KAWANAMI 1,2, MD; NORIMITSU WAKAO 1,2, MD, PhD; MITSUHIRO

More information

Testicular Tumors Including Secondary and Unusual Tumors of the Testis

Testicular Tumors Including Secondary and Unusual Tumors of the Testis Testicular Tumors Including Secondary and Unusual Tumors of the Testis Milton W. Datta Partner, Hospital Pathology Associates University of Minnesota Minneapolis, MN Topics Review Features of Germ Cell

More information

Resection of retroperitoneal residual mass after chemotherapy in patients with nonseminomatous testicular cancer

Resection of retroperitoneal residual mass after chemotherapy in patients with nonseminomatous testicular cancer Turkish Journal of Cancer Vol.31/ No. 2/2001 Resection of retroperitoneal residual mass after chemotherapy in patients with nonseminomatous testicular cancer AHMET ÖZET 1, ALİ AYDIN YAVUZ 1, MURAT BEYZADEOĞLU

More information

Guidelines on Testicular Cancer

Guidelines on Testicular Cancer Guidelines on Testicular Cancer P. Albers (chairman), W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi, A. Horwich, M.P. Laguna European Association of Urology 2009 TABLE OF CONTENTS

More information

EAU Guidelines on Testicular Cancer

EAU Guidelines on Testicular Cancer EAU Guidelines on Testicular Cancer P. Albers (Chair), W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi, A. Horwich, M.P. Laguna, N. Nicolai, J. Oldenburg Guidelines Associates: J.L.

More information

Treatment Testicular Cancer Guidelines

Treatment Testicular Cancer Guidelines Treatment Testicular Cancer Guidelines Thank you very much for reading. As you may know, people have look hundreds times for their chosen readings like this, but end up in infectious downloads. Rather

More information

Cancer. Chapter 31 Lesson 2

Cancer. Chapter 31 Lesson 2 Cancer Chapter 31 Lesson 2 Tumors All cancers are tumors- masses of tissue. Not all tumors are cancers. Some tumors are benign- noncancerous. These tumors are surrounded by membranes that prevent them

More information

BEST PRACTICES IN THE APPLICATION OF IMMUNOHISTOCHEMISTRY TO DIAGNOSTIC UROLOGIC PATHOLOGY: LESSONS FROM USES & ABUSES

BEST PRACTICES IN THE APPLICATION OF IMMUNOHISTOCHEMISTRY TO DIAGNOSTIC UROLOGIC PATHOLOGY: LESSONS FROM USES & ABUSES BEST PRACTICES IN THE APPLICATION OF IMMUNOHISTOCHEMISTRY TO DIAGNOSTIC UROLOGIC PATHOLOGY: LESSONS FROM USES & ABUSES Mahul B. Amin Professor & Chairman Department of Pathology & Laboratory Medicine Cedars-Sinai

More information

Case Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult

Case Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult Case Scenario 1 Discharge Summary A 31-year-old Brazilian male presented with a 6 month history of right-sided scrotal swelling. Backache was present for 2 months and a history of right epididymitis was

More information

Respiratory Interactive Session. Elaine Borg

Respiratory Interactive Session. Elaine Borg Respiratory Interactive Session Elaine Borg Case 1 Respiratory Cytology 55 year old gentleman Anterior mediastinal mass EBUS FNA Case 1 Respiratory Cytology 55 year old gentleman with anterior mediastinal

More information

Immunohistochemical classification of the unknown primary tumour (UPT) Part I. Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark

Immunohistochemical classification of the unknown primary tumour (UPT) Part I. Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark Immunohistochemical classification of the unknown primary tumour (UPT) Part I Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark Tumours of unknown origin: Histology Brain tumour - biopsy

More information

Diagnostic Value of EBUS-TBNA in Various Lung Diseases (Lymphoma, Tuberculosis, Sarcoidosis)

Diagnostic Value of EBUS-TBNA in Various Lung Diseases (Lymphoma, Tuberculosis, Sarcoidosis) Diagnostic Value of EBUS-TBNA in Various Lung Diseases (Lymphoma, Tuberculosis, Sarcoidosis) Sevda Sener Cömert, MD, FCCP. SBU, Kartal Dr.Lütfi Kırdar Training and Research Hospital Department of Pulmonary

More information

Testis. Protocol applies to all malignant germ cell and malignant sex cord-stromal tumors of the testis, exclusive of paratesticular malignancies.

Testis. Protocol applies to all malignant germ cell and malignant sex cord-stromal tumors of the testis, exclusive of paratesticular malignancies. Testis Protocol applies to all malignant germ cell and malignant sex cord-stromal tumors of the testis, exclusive of paratesticular malignancies. Protocol revision date: January 2005 Based on AJCC/UICC

More information

Rare Tumours of Male Genital Organs

Rare Tumours of Male Genital Organs Rare Tumours of Male Genital Organs 1. Epithelial Tumours of Prostate 1.1 General Results Table 1. Epithelial Tumours of Prostate: Incidence, Trends, Survival Flemish Region 2001-2010 Incidence Trend Survival

More information

Other Sites. Table 2 Continued. MPH Rules 11/8/07. NAACCR Webinar Series 1

Other Sites. Table 2 Continued. MPH Rules 11/8/07. NAACCR Webinar Series 1 MPH s 11/8/07 Other s 1 Table 2 Continued Use this two-page table to select combination histology codes. Compare the terms in the diagnosis to the terms in Columns 1 and 2. If the terms match, code the

More information

Tinh hoàn

Tinh hoàn Tinh hoàn Tinh hoàn Tinh hoàn Tiền liệt tuyến Tiền liệt tuyến Mào tinh hoàn Mào tinh hoàn Túi tinh Túi tinh Túi tinh Túi tinh So-called cystadenoma of seminal vesicle. Gross appearance of granulomatous

More information

Case Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult

Case Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult Case Scenario 1 Discharge Summary A 31-year-old Brazilian male presented with a 6 month history of right-sided scrotal swelling. Backache was present for 2 months and a history of right epididymitis was

More information

Kimberly Rohan ANP-BC, AOCN Nurse Practitioner Edward Cancer Center

Kimberly Rohan ANP-BC, AOCN Nurse Practitioner Edward Cancer Center Kimberly Rohan ANP-BC, AOCN Nurse Practitioner Edward Cancer Center Objective The nurse will be able to explain biomarkers and their implications to patient s prescribed treatment plan Biomarkers Use in

More information

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology Songlin Zhang, MD, PhD LSUHSC-Shreveport I have no Conflict of Interest. FNA on Lymphoproliferative

More information

Kevin P. Hubbard, DO, HMDC, MACOI

Kevin P. Hubbard, DO, HMDC, MACOI BR Kevin P. Hubbard, DO, HMDC, MACOI Professor and Chair - Department of Specialty Medicine Kansas City University of Medicine and Biosciences-College of Osteopathic Medicine Kansas City, Missouri Financial

More information

2007 ANNUAL SITE STUDY HODGKIN S LYMPHOMA

2007 ANNUAL SITE STUDY HODGKIN S LYMPHOMA 2007 ANNUAL SITE STUDY HODGKIN S LYMPHOMA SUSQUEHANNA HEALTH David B. Nagel, M.D. April 11, 2008 Hodgkin s lymphoma was first described by Thomas Hodgkin in 1832. It remained an incurable malignancy until

More information

NCCN Practice Guidelines Narrative Summary of Indications for FDG PET and PET/CT

NCCN Practice Guidelines Narrative Summary of Indications for FDG PET and PET/CT NCCN Practice Guidelines Narrative Summary of Indications for FDG PET and PET/CT NCCN guidelines were reviewed on 2/14/2016 for utilization of 18F-fluorodeoxyglucose (FDG) PET and PET/CT (available at:

More information

Radiology Pathology Conference

Radiology Pathology Conference Radiology Pathology Conference Sharlin Johnykutty,, MD, Cytopathology Fellow Sara Majewski, MD, Radiology Resident Friday, August 28, 2009 Presentation material is for education purposes only. All rights

More information

Morphologic Aspects Aspects

Morphologic Aspects Aspects Testicular Testicular Germ Germ Cell Cell Neoplasia: Neoplasia: Molecular Molecular Pathways Pathways & Challenging Morphologic Aspects Aspects George George J. J. Netto, Netto, M.D. M.D. Johns Johns Hopkins

More information

Mediastinal Tumors: Imaging

Mediastinal Tumors: Imaging Mediastinal Tumors: Imaging References Imaging in Oncology, Husband and Reznek Computed Tomography and Magnetic Resonance of the thorax, Naidich, Zerhouni, Siegelman, Mediastinal compartments Anterior:

More information

Pelvic tumor in childhood Classification, imaging approach and radiological findings

Pelvic tumor in childhood Classification, imaging approach and radiological findings Pelvic tumor in childhood Classification, imaging approach and radiological findings M. Mearadji International Foundation for Pediatric Imaging Aid Rotterdam, The Netherlands Solid pelvic masses in childhood

More information

TESTICULAR CANCER Updated March 2016 by Dr. Safiya Karim (PGY-5 Medical Oncology Resident, University of Toronto)

TESTICULAR CANCER Updated March 2016 by Dr. Safiya Karim (PGY-5 Medical Oncology Resident, University of Toronto) TESTICULAR CANCER Updated March 2016 by Dr. Safiya Karim (PGY-5 Medical Oncology Resident, University of Toronto) Reviewed by Dr. Aaron Hansen (Staff Medical Oncologist, University of Toronto) DISCLAIMER:

More information

Large cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s

Large cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s Non Hodgkin s Lymphoma Introduction 6th most common cause of cancer death in United States. Increasing in incidence and mortality. Since 1970, the incidence of has almost doubled. Overview The types of

More information

Macmillan Publications

Macmillan Publications S1 S2 S3 S3 S3 S4 S5 S6 S7 S8 S8 S9 S10 S11 S11 S12 S13 S14 S15 S17 S18 S19 Bladder Cancer: Non-Invasive, Invasive and Advanced Bone Cancer: Primary, Secondary Colon Cancer, Anal Cancer, Rectal Cancer

More information

Case Report Primary Malignancy in a Supernumerary Testicle Presenting as a Large Pelvic Mass

Case Report Primary Malignancy in a Supernumerary Testicle Presenting as a Large Pelvic Mass Hindawi Volume 2017, Article ID 4529853, 4 pages https://doi.org/10.1155/2017/4529853 Case Report Primary Malignancy in a Supernumerary Testicle Presenting as a Large Pelvic Mass Justin Noroozian, 1 Daniel

More information

Diagnosis and patient pathway in lymphomas

Diagnosis and patient pathway in lymphomas The Royal Marsden Diagnosis and patient pathway in lymphomas Dr Ian Chau Consultant Medical Oncologist The Royal Marsden Hospital London & Surrey Change Presentation title and date in Footer dd.mm.yyyy

More information

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital.

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital. Male genital tract tumors Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital. adenocarcinoma Prostate Cancer most common male cancer in western countries more detected in

More information